Moon Seongmin, Ha Yun-Sok, Kim Mina, Kim Hoseob, Kim Won Tae, Kim Yong-June, Yun Seok-Joong, Lee Sang-Cheol, Kang Ho Won
Department of Urology, Chungbuk National University Hospital, Cheongju, Korea.
Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.
Investig Clin Urol. 2025 Jan;66(1):11-17. doi: 10.4111/icu.20240255.
To describe the incidence and mortality of upper tract urothelial carcinoma (UTUC) from 2002-2020 using data from the Korean National Health Insurance Service, which contains data from the entire Korean population.
Reimbursement records for 43,255 patients diagnosed with primary UTUC (according to the International Classification of Disease 10th revision code C65 and C66) between 2002-2020 were retrieved. The study period was split into four: period I (2002-2005), period II (2006-2010), period III (2011-2015), and period IV (2016-2020). Trends were quantified by calculating the annual percentage change (APC). Mortality data were obtained from the Statistics Korea.
From 2002-2020, the incidence of UTUC in Korea increased gradually from 9.34 to 11.40 per 100,000 person-years. Although there was a male predominance, the male to female ratio did not change significantly over time; however, age at the time of diagnosis, the comorbidity index, and the proportion of patients undergoing open/laparoscopic surgery increased significantly over time. There was a modest improvement in 5-year survival (both all cause- and cancer-specific) over the study period. Multivariate analysis identified age at diagnosis, sex, the comorbidity index, and open/laparoscopic surgery as being associated with survival.
Between 2002 and 2020, the incidence of UTUC in Korea showed a general upward trend; however, survival outcomes have improved. These representative datasets from the Korean population might provide crucial information that enables clinicians to better understand of the epidemiology of UTUC in Korea.
利用韩国国民健康保险服务的数据(涵盖了全体韩国人口的数据)来描述2002年至2020年上尿路尿路上皮癌(UTUC)的发病率和死亡率。
检索了2002年至2020年间43255例被诊断为原发性UTUC(根据国际疾病分类第10版编码C65和C66)患者的报销记录。研究期分为四个阶段:第一阶段(2002 - 2005年)、第二阶段(2006 - 2010年)、第三阶段(2011 - 2015年)和第四阶段(2016 - 2020年)。通过计算年度百分比变化(APC)来量化趋势。死亡率数据来自韩国统计局。
2002年至2020年,韩国UTUC的发病率从每10万人年9.34例逐渐增加至11.40例。虽然男性占主导,但男女比例随时间没有显著变化;然而,诊断时的年龄、合并症指数以及接受开放/腹腔镜手术患者的比例随时间显著增加。在研究期间,5年生存率(全因和癌症特异性)有适度改善。多变量分析确定诊断时的年龄、性别、合并症指数以及开放/腹腔镜手术与生存率相关。
2002年至2020年,韩国UTUC的发病率呈总体上升趋势;然而,生存结果有所改善。这些来自韩国人群的代表性数据集可能提供关键信息,使临床医生能够更好地了解韩国UTUC的流行病学情况。